Arsenite retards the cardiac differentiation of rat cardiac myoblast H9c2 cells

Biochemical and Biophysical Research Communications

Volumn 436, Issue 2, 2013, Pages 175-179

  Sumi, Daigo ^a   Abe, Kazusa ^a   Himeno, Seiichiro ^a  

^a TOKUSHIMA BUNRI UNIVERSITY   (Japan)

Author keywords

Arsenic; Cardiac cells; Differentiation; H9c2 cells; PKC

Indexed keywords

ARSENIC TRIOXIDE; PROTEIN KINASE C DELTA; RETINOIC ACID; TROPONIN T;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL LINE; CELL STRUCTURE; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME PHOSPHORYLATION; EXPOSURE; G1 PHASE CELL CYCLE CHECKPOINT; HEART CELL CULTURE; MULTINUCLEAR CELL; MYOBLAST; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; ARSENITES; BLOTTING, WESTERN; CELL CYCLE CHECKPOINTS; CELL DIFFERENTIATION; CELL LINE; CULTURE MEDIA; DOSE-RESPONSE RELATIONSHIP, DRUG; FETAL BLOOD; FLOW CYTOMETRY; G0 PHASE; G1 PHASE; GIANT CELLS; MYOBLASTS, CARDIAC; MYOCYTES, CARDIAC; PHOSPHORYLATION; PROTEIN KINASE C-DELTA; RATS; TRETINOIN; TROPONIN T;

BOVINAE; RATTUS;

EID: 84879601692     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.05.069     Document Type: Article

References (34)

1. Tseng W.P., Chu H.M., How S.W., Fong J.M., Lin C.S., Yeh S. Prevalence of skin cancer in an endemic area of chronic arsenicism in Taiwan. J. Natl. Cancer Inst. 1968, 40:453-463.
2. Lagerkvist B.E., Linderholm H., Nordberg G.F. Arsenic and Raynaud's phenomenon. Vasospastic tendency and excretion of arsenic in smelter workers before and after the summer vacation. Int. Arch. Occup. Environ. Health 1988, 60:361-364.
3. Engel R.R., Hopenhayn-Rich C., Receveur O., Smith A.H. Vascular effects of chronic arsenic exposure: a review. Epidemiol. Rev. 1994, 16:184-209.
4. Wang C.H., Chen C.L., Hsiao C.K., Chiang F.T., Hsu L.I., Chiou H.Y., Hsueh Y.M., Wu M.M., Chen C.J. Increased risk of QT prolongation associated with atherosclerotic diseases in arseniasis-endemic area in southwestern coast of Taiwan. Toxicol. Appl. Pharmacol. 2009, 239:320-324.
5. Zhao X.Y., Li G.Y., Liu Y., Chai L.M., Chen J.X., Zhang Y., Du Z.M., Lu Y.J., Yang B.F. Resveratrol protects against arsenic trioxide-induced cardiotoxicity in vitro and in vivo. Br. J. Pharmacol. 2008, 154:105-113.
6. Li Y., Sun X., Wang L., Zhou Z., Kang Y.J. Myocardial toxicity of arsenic trioxide in a mouse model. Cardiovasc. Toxicol. 2002, 2:63-73.
7. Wu M.H., Lin C.J., Chen C.L., Su M.J., Sun S.S., Cheng A.L. Direct cardiac effects of As2O3 in rabbits: evidence of reversible chronic toxicity and tissue accumulation of arsenicals after parenteral administration. Toxicol. Appl. Pharmacol. 2003, 189:214-220.
8. Sumi D., Sasaki T., Miyataka H., Himeno S. Rat H9c2 cardiac myocytes are sensitive to arsenite due to a modest activation of transcription factor Nrf2. Arch. Toxicol. 2011, 85:1509-1516.
9. Hopenhayn-Rich C., Browning S.R., Hertz-Picciotto I., Ferreccio C., Peralta C., Gibb H. Chronic arsenic exposure and risk of infant mortality in two areas of Chile. Environ. Health Perspect. 2000, 108:667-673.
10. Ahmad S.A., Sayed M.H., Barua S., Khan M.H., Faruquee M.H., Jalil A., Hadi S.A., Talukder H.K. Arsenic in drinking water and pregnancy outcomes. Environ. Health Perspect. 2001, 109:629-631.
11. He W., Greenwell R.J., Brooks D.M., Calderon-Garciduenas L., Beall H.D., Coffin J.D. Arsenic exposure in pregnant mice disrupts placental vasculogenesis and causes spontaneous abortion. Toxicol. Sci. 2007, 99:244-253.
12. Li D., Lu C., Wang J., Hu W., Cao Z., Sun D., Xia H., Ma X. Developmental mechanisms of arsenite toxicity in zebrafish (Danio rerio) embryos. Aquat. Toxicol. 2009, 91:229-237.
13. Branco A.F., Pereira S.L., Moreira A.C., Holy J., Sardao V.A., Oliveira P.J. Isoproterenol cytotoxicity is dependent on the differentiation state of the cardiomyoblast H9c2 cell line. Cardiovasc. Toxicol. 2011, 11:191-203.
14. Schopf G., Rumpold H., Muller M.M. Alterations of purine salvage pathways during differentiation of rat heart myoblasts towards myocytes. Biochim. Biophys. Acta 1986, 884:319-325.
15. Menard C., Pupier S., Mornet D., Kitzmann M., Nargeot J., Lory P. Modulation of L-type calcium channel expression during retinoic acid-induced differentiation of H9C2 cardiac cells. J. Biol. Chem. 1999, 274:29063-29070.
16. Uruno A., Noguchi N., Matsuda K., Nata K., Yoshikawa T., Chikamatsu Y., Kagechika H., Harigae H., Ito S., Okamoto H., Sugawara A. All-trans retinoic acid and a novel synthetic retinoid tamibarotene (Am80) differentially regulate CD38 expression in human leukemia HL-60 cells: possible involvement of protein kinase C-delta. J. Leukoc. Biol. 2011, 90:235-247.
17. Zhao K.W., Li X., Zhao Q., Huang Y., Li D., Peng Z.G., Shen W.Z., Zhao J., Zhou Q., Chen Z., Sims P.J., Wiedmer T., Chen G.Q. Protein kinase Cdelta mediates retinoic acid and phorbol myristate acetate-induced phospholipid scramblase 1 gene expression: its role in leukemic cell differentiation. Blood 2004, 104:3731-3738.
18. di Giacomo V., Rapino M., Sancilio S., Patruno A., Zara S., Di Pietro R., Cataldi A. PKC-delta signalling pathway is involved in H9c2 cells differentiation. Differentiation 2010, 80:204-212.
19. Chen Y., Wu F., Parvez F., Ahmed A., Eunus M., McClintock T.R., Patwary T.I., Islam T., Ghosal A.K., Islam S., Hasan R., Levy D., Sarwar G., Slavkovich V., van Geen A., Graziano J.H., Ahsan H. Arsenic exposure from drinking water and QT-interval prolongation: results from the health effects of arsenic longitudinal study. Environ. Health Perspect. 2013, 121:427-432.
20. Mumford J.L., Wu K., Xia Y., Kwok R., Yang Z., Foster J., Sanders W.E. Chronic arsenic exposure and cardiac repolarization abnormalities with QT interval prolongation in a population-based study. Environ. Health Perspect. 2007, 115:690-694.
21. Ohnishi K., Yoshida H., Shigeno K., Nakamura S., Fujisawa S., Naito K., Shinjo K., Fujita Y., Matsui H., Sahara N., Takeshita A., Satoh H., Terada H., Ohno R. Arsenic trioxide therapy for relapsed or refractory Japanese patients with acute promyelocytic leukemia: need for careful electrocardiogram monitoring. Leukemia 2002, 16:617-622.
22. Zhang T.D., Chen G.Q., Wang Z.G., Wang Z.Y., Chen S.J., Chen Z. Arsenic trioxide, a therapeutic agent for APL. Oncogene 2001, 20:7146-7153.
23. Westervelt P., Brown R.A., Adkins D.R., Khoury H., Curtin P., Hurd D., Luger S.M., Ma M.K., Ley T.J., DiPersio J.F. Sudden death among patients with acute promyelocytic leukemia treated with arsenic trioxide. Blood 2001, 98:266-271.
24. Smith A.H., Marshall G., Yuan Y., Ferreccio C., Liaw J., von Ehrenstein O., Steinmaus C., Bates M.N., Selvin S. Increased mortality from lung cancer and bronchiectasis in young adults after exposure to arsenic in utero and in early childhood. Environ. Health Perspect. 2006, 114:1293-1296.
25. Kozul-Horvath C.D., Zandbergen F., Jackson B.P., Enelow R.I., Hamilton J.W. Effects of low-dose drinking water arsenic on mouse fetal and postnatal growth and development. PLoS One 2012, 7:e38249.
26. Wang Z.X., Jiang C.S., Liu L., Wang X.H., Jin H.J., Wu Q., Chen Q. The role of Akt on arsenic trioxide suppression of 3T3-L1 preadipocyte differentiation. Cell Res. 2005, 15:379-386.
27. Yen Y.P., Tsai K.S., Chen Y.W., Huang C.F., Yang R.S., Liu S.H. Arsenic inhibits myogenic differentiation and muscle regeneration. Environ. Health Perspect. 2010, 118:949-956.
28. Steffens A.A., Hong G.M., Bain L.J. Sodium arsenite delays the differentiation of C2C12 mouse myoblast cells and alters methylation patterns on the transcription factor myogenin. Toxicol. Appl. Pharmacol. 2011, 250:154-161.
29. Au K.W., Kou C.Y., Woo A.Y., Chim S.S., Fung K.P., Cheng C.H., Waye M.M., Tsui S.K. Calcyclin binding protein promotes DNA synthesis and differentiation in rat neonatal cardiomyocytes. J. Cell. Biochem. 2006, 98:555-566.
30. Breen E.C., Tang K. Calcyclin (S100A6) regulates pulmonary fibroblast proliferation, morphology, and cytoskeletal organization in vitro. J. Cell. Biochem. 2003, 88:848-854.
31. Ron D., Kazanietz M.G. New insights into the regulation of protein kinase C and novel phorbol ester receptors. FASEB J. 1999, 13:1658-1676.
32. Paul D.S., Harmon A.W., Devesa V., Thomas D.J., Styblo M. Molecular mechanisms of the diabetogenic effects of arsenic: inhibition of insulin signaling by arsenite and methylarsonous acid. Environ. Health Perspect. 2007, 115:734-742.
33. Pagano M., Naviglio S., Spina A., Chiosi E., Castoria G., Romano M., Sorrentino A., Illiano F., Illiano G. Differentiation of H9c2 cardiomyoblasts: the role of adenylate cyclase system. J. Cell. Physiol. 2004, 198:408-416.
34. Hunter A.L., Zhang J., Chen S.C., Si X., Wong B., Ekhterae D., Luo H., Granville D.J. Apoptosis repressor with caspase recruitment domain (ARC) inhibits myogenic differentiation. FEBS Lett. 2007, 581:879-884.